Clinical Observations on the Rectal and Oral Use of Various Ergot Derivatives in Headache
- 13 April 1950
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 242 (15) , 581-582
- https://doi.org/10.1056/nejm195004132421504
Abstract
CLINICAL observations have recently been reported on the use of Cafergone, a new anticephalalgic agent for oral use consisting of 1 mg. of ergotamine tartrate and 100 mg. caffeine alkaloid. Several observers1 2 3 4 5 6 reported excellent results with Cafergone orally in vascular headache, and it was the consensus of most that Cafergone is effective in the treatment of migraine, especially when taken early and in adequate dosage, and that it is also of value in combating psychogenic headache. The results were especially encouraging in headache caused by overindulgence, as well as in that associated with fever and photophobia.In patients in whom . . .Keywords
This publication has 1 reference indexed in Scilit:
- Cafergone For Relief of HeadachePostgraduate Medicine, 1949